NCT05984680Completed
COPD Care Pathway Among Patients With Cancer
User-Centered Design of a COPD Care Pathway for Patients With Cancer
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 101 (actual)
- First submitted
- 1 Aug 2023
- Start date
- Feb 2025
- Primary completion date
- Mar 2026
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Head and neck cancer, COPD, Lung cancer
- NCT number
- NCT05984680
What you commit to
- Study type: Observational
- Participants enrolled: 101
- From Feb 2025 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
- patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
- provider who currently works at least part-time in a medical oncology clinic or
- provider who works at least part-time to care for patients with known or suspected COPD.
- A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
- Ability to understand and agree to participate on the study as described by the study information sheet.
- Capability of speaking or reading English.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wake Forest Baptist Comprehensive Cancer Center Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.